|
|||||
|
|
Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation |
|
| Authors: | Winnie W. Nelson Xue Song Craig I. Coleman Erin Thomson David M. Smith C.V. Damaraju |
| Affiliation: | 1. Janssen Scientific Affairs, LLCRaritan, NJUSA;2. Truven Health AnalyticsAnn Arbor, MIUSA;3. University of ConnecticutHartford, CTUSA |
| Abstract: | |
| Keywords: | Non-valvular atrial fibrillation Persistence Rivaroxaban Warfarin |